| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.009 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.009 |